BTLA anticorps (AA 31-150)

N° du produit ABIN7092980

Cet anticorps anti-BTLA Monoclonal Lapin (Clone DM182) (ABIN7092980) détecte spécifiquement BTLA dans FACS et ELISA. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour BTLA anticorps (AA 31-150) (ABIN7092980)

Antigène: BTLA (B and T Lymphocyte Associated (BTLA))

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp BTLA est non-conjugé

Application: Flow Cytometry (FACS), ELISA

Clone: DM182

Détail du produit anti-BTLA anticorps

Épitope: AA 31-150

Fonction: Anti-BTLA antibody(DM182), Rabbit mAb

Purification: Purified from cell culture supernatant by affinity chromatography

Immunogène: Recombinant human BTLA(Lys31-Ser150) (ABIN6961116) produced by using human HEK293 cells

Isotype: IgG

Information d'application

Indications d'application: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur BTLA

Antigène: BTLA (B and T Lymphocyte Associated (BTLA))

Autre désignation: BTLA

Sujet: Synonyms:BTLA, CD272
Description:This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.

Poids moléculaire: 32.8KDa

UniProt: Q7Z6A9

Pathways: Cancer Immune Checkpoints